Clinical Trials Directory

Intervention Development for Anxiety in Metastatic NSCLC Patients and Their Caregivers

This pilot clinical trial studies cognitive behavioral therapy in treating anxiety in patients with stage IV non-small cell lung cancer and their caregivers. Cognitive behavioral therapy may reduce anxiety and improve the well-being and quality of life of patients who have stage IV non-small cell lung cancer and their caregivers.

Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.

Intervention(s):

  • other : counseling intervention
  • other : questionnaire administration
  • procedure : quality-of-life assessment

Phase: N/A

Eligibility

Ages Eligible For Study:

N/A - N/A

Inclusion Criteria

- Diagnosis of stage IV non-small cell lung cancer - At least 6 weeks post-diagnosis - Current symptoms of anxiety (e.g., Hamilton Rating Scale for Anxiety [HAM-A] >=14) - Ability to understand and the willingness to sign a written informed consent document - CAREGIVER: Identified by patient as primary caregiver - CAREGIVER: At least 14 hours/week spent caring for patient - CAREGIVER: Current symptoms of anxiety (e.g., HAM-A >= 14) - CAREGIVER: Ability to understand and the willingness to sign a written informed consent document

External Links

Explore related trials

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Ellen Hendriksen
650-725-5424
Not Recruiting

Footer Links: